The partnership means that Apple's fitness and wellness service will be made available to all members who enrol onto ...

Americans are flocking to new weight loss medications like Novo Nordisk’s Wegovy and Eli Lilly's Zepbound, which work by ...

World markets have hunkered down for three days of economic health checks, corporate readouts and policy decisions that may define the remainder of the summer, with U.S. trade worries easing somewhat ...

Novo Nordisk's steep stock decline has pushed it into deep undervaluation, now trading at attractive multiples below ...

Novo Nordisk's growth in diabetes and obesity care makes it a strong buy. Click here for a full investment analysis of NVO ...

As results season winds down, Dan Jones and team discuss a property group’s results, alternative ways to find bargain stocks and Novo Nordisk vs Eli Lilly ...

Novo Nordisk has named Maziar Mike Doustdar, currently the compan | Novo Nordisk has named Maziar Mike Doustdar, currently the company’s EVP of international operations, as the new CEO.

Novo Nordisk announced that Mike Doustdar has been appointed as the new CEO on Tuesday.

Shares in Novo Nordisk NOVO.B-2.27%decrease; red down pointing triangle plunged after it cut its guidance, a result from the company losing its lead in the booming market for weight-loss drugs ...

Novo Nordisk announced company veteran Maziar Mike Doustdar as its next CEO, as the firm struggles to regain its dominance in the obesity market.